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CryoAblation of Atrial Fibrillation:  
New Technique / New Expectations
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Prokopis Papadimitriou, MD, Emmanouil Poulidakis, MD,  
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A 53-year-old gentleman with frequent episodes of idiopathic paroxysmal atrial 
fibrillation (AF) who had failed rhythm control with two antiarrhythmic drugs was ini-
tially submitted to an ablation procedure during which pulmonary vein (PV) isolation 
was performed with use of a cryothermic balloon in September 2012. After a 3-month 
blanking period, he remained free of symptoms for over a year. However, over the last 
one month he has had frequent arrhythmia recurrences with almost weekly episodes. 
He returned for a repeat ablation procedure.
During the procedure the left atrium was accessed via transseptal catheterization. 
With use of a circular mapping catheter, electrical activity was assessed within each 
pulmonary vein. No activity was recorded in the right pulmonary veins. The left pul-
monary veins drained into the left atrium via a common trunk (left upper panel, white 
arrow). Pulmonary vein potentials indicating electrical reconnections were detected in 
the left pulmonary veins at several points around the perimeter of the veins (left lower 
panel, black arrows). Subsequently, the veins were successfully re-isolated with use of 
a second generation 28-mm cryoballoon (mid upper panel, black arrow) by applying 
3 cryothermic lesions each of 200-240 seconds in duration at the antrum of the left 
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pulmonary veins. Upon obtaining new local recordings with 
use of the circular catheter (mid upper panel, white arrow; 
right upper panel, black arrow), absence of PV potentials was 
confirmed (right lower panel; PV potentials indicated with 
black arrows in the left lower panel are absent in the right lower 
panel). Several spontaneous episodes of AF recorded during 
the procedure promptly ceased to recur after completion of 
the cryothermic lesions.
●●●
Pulmonary vein isolation with use of radiofrequency abla-
tion is the most common ablation technique for paroxysmal 
and/or persistent atrial fibrillation (AF).1 Using cryothermic 
ablation via a cryoballoon is an alternative, more recently 
developed, rapidly growing technique. The STOP AF trial has 
demonstrated that cryoballoon ablation is a safe and effective 
alternative to antiarrhythmic medication for the treatment of 
patients with symptomatic paroxysmal AF.2 This technology 
has already advanced to a second generation cryoballoon con-
sidered to deliver more effective lesions.3 Results of cryoabla-
tion appear at least to be similar with those of radiofrequency 
ablation, while some investigators have suggested that this may 
be a faster and possibly safer or even more effective technique.4 
A recent study indicated that use of second-generation 28-mm 
cryoballoon for pulmonary vein isolation resulted in an 80% 
1-year success rate.5 Another study showed that procedural 
times were significantly shorter in the cryoballon approach 
compared with the radiofrequency method. The most frequent 
complication during cryoballoon procedures was phrenic nerve 
palsy, which may occur in up to ~10% of patients, but usually 
resolves during the follow-up period.4,6-8
Ablation techniques for AF are plagued by frequent early 
and late recurrences, reported to occur in around 30-50% of 
patients, requiring reablation, which is subsequently associated 
with better long-term freedom from recurrent AF.6 The main 
reason for AF recurrences after an initial procedure is mostly 
related to reconnections (recovery of conduction between the 
PVs and the left atrium) at some segments of the perimeter of 
PVs, rather than extrapulmonary sources. This was the cause 
of AF recurrence in the present case, which was effectively 
remedied with re-ablation, which makes a repeat procedure 
worth performing in patients with a recurring arrhythmia.
Cryoablation with the cryoballoon is a rapidly emerging 
alternative and promising technique with a favorable safety 
profile for AF ablation used to achieve circumferential PV 
isolation. Phrenic nerve palsy while ablating the right PVs is 
more common with cryoablation rather than radiofrequency 
ablation, albeit rarely a permanent complication. This new 
technique has raised expectations for a faster, safer (less 
thrombogenic and/or less traumatic to the esophagus) and 
perhaps more effective tool for PV isolation in patients with 
paroxysmal and/or persistent AF.8 However, head-to-head 
comparisons with radiofrequency ablation are needed before 
this technique is more widely adopted.
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